Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States
Abstract
Background. The Panel on Cost-Effectiveness in Health and Medicine has called for an “off-the-shelf” catalogue of nationally representative, community-based preference scores for health states, illnesses, and conditions. A previous review of cost-effectiveness analyses found that 77% did not incorporate community-based preferences, and 33% used arbitrary expert or author judgment. These results highlight the necessity of making a wide array of appropriate, community-based estimates more accessible to cost-effectiveness researchers. Objective. To provide nationally representative EQ-5D index scores for chronic ICD-9 codes. Methods. The nationally representative Medical Expenditure Panel Survey (MEPS) was pooled (2000–2002) to create a data set of 38,678 adults. Ordinary least squares (OLS), Tobit, and censored least absolute deviations (CLAD) regression methods were used to estimate the marginal disutility of each condition, controlling for age, comorbidity, gender, race, ethnicity, income, and education. Results. Most chronic conditions, age, comorbidity, income, and education were highly statistically significant predictors of EQ-5D index scores. Homoskedasticity and normality assumptions were rejected, suggesting only CLAD estimates are theoretically unbiased. The magnitude and statistical significance of coefficients varied by analytic method. OLS and Tobit coefficients were on average 60% and 143% greater than CLAD, respectively. The marginal disutility of 95 chronic ICD-9 codes as well as unadjusted mean, median, and 25th and 75th percentiles are reported.Conclusion. This research provides nationally representative, communitybased EQ-5D index scores associated with a wide variety of chronic ICD-9 codes that can be used to estimate quality-adjusted life-years in cost-effectiveness analyses.
Get full access to this article
View all access and purchase options for this article.
References
Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
Drummond MF. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford, UK: Oxford University Press; 1997.
Bell CM, Chapman RH, Stone PW, Sandberg EA, Neumann PJ. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Med Decis Making. 2001;21:288–294.
Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89–102.
Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care. 1998;36:778–792.
Erickson P, Wilson R, Shannon I. Years of Healthy Life. Atlanta, GA: Centers for Disease Control and Prevention; 1995.
Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care. 2000;38:583–637.
Sullivan PW, Lawrence WF Jr, Ghushchyan V. A national catalogue of preference-based scores for chronic conditions in the U.S. Med Care. 2005;43:736–749.
Elixhauser A, Andrews RM, Fox S. Clinical Classifications for Health Policy Research: Discharge statistics by principal diagnosis and procedure. AHCPR Pub. No. 93-0043. Rockville, MD: Agency for Health Policy and Research; 1993.
Agency for Healthcare Research and Quality (AHRQ). Puf Documentation Files. Agency for Healthcare Research and Quality (AHRQ). Available at: http://www.meps.ahrq.gov/PUFFiles/H52/H52doc.htm. Accessed 10 November 2003.
US Health Care Financing Administration. The International Classification of Diseases, 9th revision, Clinical Modification: ICD-9-CM. 2nd ed. Washington, DC: US Department of Health and Human Services, Public Health Service; 1980.
The EuroQol Group. Available at: http://www.euroqol.org/download/ref.pdf. Accessed 11 November 2003.
McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. 2nd ed. New York: Oxford University Press; 1996.
Shaw JW, Johnson JA, Coons SJ. U.S. valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43;203–220.
Agency for Healthcare Research and Quality. Computing Standard Errors for MEPS Estimates. Rockville, MD: Agency for Healthcare Research and Quality. Accessed September 2003.
Hwang W, Weller W, Ireys H, Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood). 2001;20:267–278.
Austin PC. Bayesian extensions of the Tobit model for analyzing measures of health status. Med Decis Making. 2002;22:152–162.
Powell J. Least absolute deviations estimation for the censored regression model. J Econometrics. 1984;25:303–325.
Maddala GS. Limited-Dependent and Qualitative Variables in Econometrics. Cambridge, UK: Cambridge University Press; 1999.
Green WH. Econometric Analysis. 4th ed. Upper Saddle River, NJ: Prentice Hall; 2000.
Petersen D, Waldman D. The treatment of heteroscedasticity in the limited dependent variable model. Mimeo. November 1981.
The ICD-9 to CCC crosswalk is available in the Medical Conditions Public Use Files (MEPS HC-069) at www.meps.ahrq (appendix 3, p A3-1).
Berkanovic E, Telesky C. Mexican-American, black-American and white-American differences in reporting illnesses, disability and physician visits for illnesses. Soc Sci Med. 1985;20:567–577.
Stewart AL, Napoles-Springer A. Health-related quality-of-life assessments in diverse population groups in the United States. Med Care. 2000;38(9 Suppl):II102–II124.
Johnson TP, O'Rourke D, Chavez N, Sudman S. Cultural variations in the interpretation of health survey questions. In: Warnecke RB, ed. Health Survey Research Methods. Hyattsville, MD: National Center for Health Statistics; 1996. p 57–62.
Glick HA, Polsky D, Willke RJ, Schulman KA. A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Making. 1999;19:265–275.
Wu AW, Jacobson KL, Frick KD, et al. Validity and responsiveness of the Euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res. 2002;11:273–282.
Macran S, Weatherly H, Kind P. Measuring population health: a comparison of three generic health status measures. Med Care. 2003;41:218–231.
Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care. 2002;40:113–128.
Richardson J. Cost utility analysis: what should be measured? Soc Sci Med. 1994;39:7–21.
Llewellyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NF. The measurement of patients' values in medicine. Med Decis Making. 1982;2:449–462.
Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. 2nd ed. Princeton, NJ: Princeton University Press; 1947.
Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1–30.
Luo N, Chew LH, Fong KY, et al. A comparison of the EuroQol-5D and the Health Utilities Index Mark 3 in patients with rheumatic disease. J Rheumatol. 2003;30:2268–2274.
Bosch JL, Hunink MG. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res. 2000;9:591–601.
Supplementary Material
File (mdm290495-online_appendix.pdf)
- Download
- 43.53 KB
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published: July/August 2006
Issue published: July/August 2006
Keywords
History
Published online: July 1, 2006
Issue published: July/August 2006
PubMed: 16855129
Authors
Metrics and citations
Metrics
Article usage*
Total views and downloads: 1248
*Article usage tracking started in December 2016
Articles citing this one
Web of Science: 208 view articles Opens in new tab
Crossref: 488
- Assessment of health-related quality of life and health status in pati...
- Cost-effectiveness analysis of empagliflozin in patients with heart fa...
- Effectiveness and Cost-Effectiveness of Team-Based Care for Hypertensi...
- Cost-Effectiveness of Dapagliflozin vs Empagliflozin for Treating Hear...
- Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, D...
- Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Cil...
- Economic Evaluation of Endoscopic vs Open Vein Harvesting
- Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for th...
- Cost‐effectiveness of screening for paroxysmal atrial fibrillation in ...
- The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamyd...
- Estimates of Quality-Adjusted Life-Year Loss for Injuries in the Unite...
- Cost-Effectiveness of Smoking Cessation Interventions in Patients With...
- The Influence of Multilevel Spinal Deformity Surgery on the EuroQol 5 ...
- Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by ...
- Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review
- Health State Utility Values of Type 2 Diabetes Mellitus and Related Co...
- Lifetime quality-adjusted life years lost due to genital herpes acquir...
- Cost‐utility analysis of emicizumab for the treatment of severe hemoph...
- Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combinat...
- Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Du...
- The Impact of Funding Inpatient Treatments for COVID-19 on Health Equi...
- A Microsimulation Study of the Cost-Effectiveness of Hepatitis C Virus...
- The economics of TAVI: A systematic review
- Cost-Effectiveness of Empagliflozin in Combination with Standard Care ...
- Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: A...
- Catalog of EQ-5D-3L Health-Related Quality-of-Life Scores for 199 Chro...
- Catalogue of socioeconomic disparities and characteristics of 199+ chr...
- Determinants of health-related quality of life across the spectrum of ...
- The benefits of care: treated HIV infection and health-related quality...
- A European multinational cost-effectiveness analysis of empagliflozin ...
- Systematic review of the evidence sources applied to cost-effectivenes...
- Evidence-based cardiovascular magnetic resonance cost-effectiveness ca...
- An economic evaluation of intensive hypertension control in CKD patien...
- Priorities among effective clinical preventive services in British Col...
- Establishment of Mono-scaled Benefit/Risk Analysis of HPV Vaccine
- Cost-effectiveness of Compression Therapy With Early Endovenous Ablati...
- Long-Term Cost-Effectiveness of Fractional Flow Reserve–Based Percutan...
- Estimated costs and quality-adjusted life-years lost due to N. gonorrh...
- Cost-Effectiveness of Intensive Versus Standard Blood Pressure Treatme...
- The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Thera...
- Benefit–harm analysis of azithromycin for the prevention of acute exac...
- Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA...
- Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspens...
- Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and...
- An economic evaluation of knee osteoarthritis treatments in Thailand
- Catalogue of multimorbidity mean based severity and associational prev...
- Patient-Reported Outcomes for Function and Pain in Total Knee Arthropl...
- Survivorship and clinical outcomes of total elbow arthroplasty using t...
- A National Catalog of Mapped Short-Form Six-Dimension Utility Scores f...
- Patient-reported health-related quality of life from a randomized, pla...
- Cost–utility analysis of risk-reducing strategies to prevent breast an...
- Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatme...
- Development and validation of the age-associated dementia policy (AgeD...
- Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Car...
- A Systematic Literature Review of Health Utility Values in Breast Canc...
- Integrating a Polygenic Risk Score for Coronary Artery Disease as a Ri...
- Chronic vestibular syndromes in the elderly: Presbyvestibulopathy—an i...
- A Cost-Utility Analysis of Remote Pulse-Oximetry Monitoring of Patient...
- Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in...
- Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 ...
- Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atr...
- The effect of carpal tunnel release on health-related quality of life ...
- Systematic Literature Review to Identify Utility Values in Patients wi...
- Systematic Literature Review to Assess Economic Evaluations in Spinal ...
- Cost‐effectiveness of anticoagulants for preventing stroke in patients...
- Cost and Quality of Life Outcomes of the STepped Exercise Program for ...
- Cost-effectiveness analysis of intensive blood pressure control in Kor...
- Intensity‐modulated proton radiation therapy as a radical treatment mo...
- Personalized Chronic Disease Follow‐Up Appointments: Risk‐Stratified C...
- The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implant...
- Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hos...
- Revealed Preference in Medical Decisions
- ACL reconstruction for all is not cost-effective after acute ACL ruptu...
- Screening for primary aldosteronism in the hypertensive obstructive sl...
- Establishing Cost-Effective Allocation of Proton Therapy for Patients ...
- Imaging of Patients Suspected of SLAP Tear: A Cost-Effectiveness Study
- Belantamab mafodotin for the treatment of relapsed/refractory multiple...
- The effects of family physician-contracted service on health-related q...
- Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in...
- Economic evaluation of process utility: elucidating preferences for a ...
- Cost utility analysis of Remdesivir and Dexamethasone treatment for ho...
- Cost-effectiveness evaluation of add-on dapagliflozin for heart failur...
- General population normative data for the EQ-5D-3L in the five largest...
- Economic Evaluation of Budesonide Orodispersible Tablets for the Treat...
- A Practical Guide to Understanding Cost-Effectiveness Analyses
- Health Inequality Analysis in Europe: Exploring the Potential of the E...
- Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acut...
- Cost-effectiveness of obeticholic acid for the treatment of non-alcoho...
- Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Mo...
- Lifetime Cost-effectiveness of Oral Semaglutide Versus Dulaglutide and...
- Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With...
- Health Impact and Cost-Effectiveness of Achieving the National Salt an...
- Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer D...
- Dupilumab Significantly Modulates Pain and Discomfort in Patients With...
- Atherosclerotic cardiovascular disease thresholds for statin initiatio...
- Sagittal balance of the cervical spine
- Health utilities for non‐melanoma skin cancers and pre‐cancerous lesio...
- Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for ...
- Economic and clinical burden of comorbidities among patients with acro...
- The effect of sexual dysfunction on health-related quality of life in ...
- Population norms for quality adjusted life years for the United States...
- One-Year Quality of Life Post–Pneumonia Diagnosis in Japanese Adults
- To ban or not to ban tanning bed use for minors: A cost‐effectiveness ...
- Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure...
- Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin ...
- Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black B...
- Accuracy Requirements for Cost-effective Suicide Risk Prediction Among...
- Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin...
- Media Influence on Anxiety, Health Utility, and Health Beliefs Early i...
- Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent ...
- Disappointing Relationship between Functional Performance and Patient ...
- The effect of adherence on antihypertensive therapy plans in patients ...
- A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalize...
- Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Man...
- Alignment, Classification, Clinical Evaluation, and Surgical Treatment...
- Cost-effectiveness analysis of radiotherapy techniques for whole breas...
- Individualised selection of left‐sided breast cancer patients for prot...
- Critical Care Beds With Continuous Lateral Rotation Therapy to Prevent...
- Cost‐effectiveness analysis of empagliflozin versus sitagliptin as ...
- Health State Utilities of Patients with Heart Failure: A Systematic Li...
- Utility Decrements Associated With Diabetes and Related Complications:...
- The cost-effectiveness of schistosomiasis screening and treatment amon...
- A Benefit-Harm Analysis of Azithromycin for the Prevention of Acute Ex...
- Cost-Effectiveness Analysis of Hypertension Screening in the Korea Nat...
- Systematic Review of Health State Utility Values Used in European Phar...
- Health-Related Quality of Life and Health Utilities of Mild, Moderate,...
- Economic value of vaccines to address the COVID-19 pandemic: a U.S. co...
- Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adu...
- A cost-effectiveness analysis model of Preventicus atrial fibrillation...
- Cost-effectiveness analysis of proton beam therapy for treatment decis...
- Cost-effectiveness analysis of advanced radiotherapy techniques for po...
- Updating the Cost Effectiveness of Oral Anticoagulants for Patients wi...
- Alternative Approaches to Quality-Adjusted Life-Year Estimation Within...
- Hepatitis C Management at Federally Qualified Health Centers during th...
- Can we predict outcome after treatment of long bone osteomyelitis?
- Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Ch...
- Comparison between radiography and magnetic resonance imaging for the ...
- HTA’d in the USA: A Comparison of ICER in the United States with NICE ...
- Health Impact and Cost-Effectiveness of Volume, Tiered, and Absolute S...
- The cost-effectiveness of sub-epidermal moisture scanning to assess pr...
- Cost-effectiveness of Contemporary Statin Use Guidelines With or Witho...
- Cost-Effectiveness of Extended and One-Time Screening Versus No Screen...
- Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonanc...
- A Nationwide Study of Prevalence Rates and Characteristics of 199 Chro...
- Disease Severity and Quality of Life in Patients With Idiopathic Pulmo...
- „Patient reported outcome measurements“ in Orthopädie und Unfallchirur...
- Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120...
- Cost-effectiveness analysis of rituximab with methotrexate, cytarabine...
- Angiotensin II for the treatment of distributive shock in the intensiv...
- Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, ...
- Health outcome measures and determinants of using indigenous medicine ...
- Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagu...
- A bronchial‐airway gene‐expression classifier to improve the diagnosis...
- Probiotics in hospitalized adult patients: a systematic review of econ...
- Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We ...
- Development and validation of the unifying elective orthopaedic score ...
- Mapping to Quality of Life and Capability Measures in Cataract Surgery...
- Analysis of EQ-5D Values
- The Challenges of Living with and Caring for a Child or Children Affec...
- Cost-effectiveness of dabrafenib and trametinib in combination as adju...
- Cost-effectiveness analysis of percutaneous mitral valve repair with t...
- Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy...
- Comparing the needs and preferences of patients with moderate and seve...
- Gender differences in the association between body mass index and heal...
- Cost-effectiveness of a statewide public health intervention to reduce...
- PRIMEtime CE: a multistate life table model for estimating the cost-ef...
- Assessing the social cost and benefits of a national requirement estab...
- Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to R...
- Projected Cost-Effectiveness for 2 Gene-Drug Pairs Using a Multigene P...
- Cost-effectiveness of integrating buprenorphine-naloxone treatment for...
- An economic analysis of medical and surgical management of aortopathy ...
- Cost-Effectiveness of More Intensive Blood Pressure Treatment in Patie...
- Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adu...
- FDA Sodium Reduction Targets and the Food Industry: Are There Incentiv...
- Outcomes and costs of remote patient monitoring among patients with im...
- Using Patient-Specific Quality Information to Unlock Hidden Healthcare...
- Cost-Effectiveness of the US Food and Drug Administration Added Sugar ...
- How does the Cox maze procedure compare? Cost-effectiveness analysis o...
- Comparison of quality of life measurements: EQ-5D-5L versus disease/tr...
- Societal willingness to pay to avoid mortality and morbidity from Clos...
- Estimating Joint Health Condition Utility Values
- Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment ...
- Discrepancies between self-reported hearing difficulty and hearing los...
- Health-Related Quality of Life and Its Determinants among Criminal Pol...
- A cost–utility analysis of dulaglutide versus insulin glargine as thir...
- Intracerebral hemorrhage outcome: A comprehensive update
- Value of hospital resources for effective pressure injury prevention: ...
- Racial and Income Disparities in Health-Related Quality of Life among ...
- The cost-effectiveness of alemtuzumab in the management of relapse-rem...
- The Preference of Lid Height and Laterality with an Ocular Prosthesis ...
- Cost-Effectiveness of Rate- and Rhythm-Control Drugs for Treating Atri...
- Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prev...
- Postacute care model of stroke in one hospital
- Long-term outcomes after operative treatment for tibial pilon fracture...
- Clinical and Economic Benefits of Upper Airway Stimulation for Obstruc...
- Cost-effectiveness of axicabtagene ciloleucel for adult patients with ...
- Healthy Parent Carers programme: development and feasibility of a nove...
- Modelling the cost-effectiveness of pay-for-performance in primary car...
- Health-related quality of life impact of minor and major bleeding even...
- Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzhe...
- Comparison of the Marginal Utility and Disease Burden of Hearing Loss ...
- Economically Efficient Hepatitis C Virus Treatment Prioritization Impr...
- Cost-effectiveness of Financial Incentives for Patients and Physicians...
- Utility elicitation in adults and children for allergic rhinoconjuncti...
- Population-level Outcomes and Cost-Effectiveness of Expanding the Reco...
- Cost-effectiveness analysis of real-time continuous monitoring glucose...
- Prices For Common Cardiovascular Drugs In The US Are Not Consistently ...
- Text Messaging to Improve Disease Management in Patients With Painful ...
- A Guide to the Economics of Hepatitis C Virus Cure in 2017
- Comparison Between Image-Guided and Landmark-Based Glenohumeral Joint ...
- Evaluating health-related quality of life impact of chronic conditions...
- Radiographic knee osteoarthritis impacts multiple dimensions of health...
- Factors associated with quality of life and functional disability amon...
- Estimating the health and economic effects of the proposed US Food and...
- Development and validation of a new population-based simulation model ...
- Cost-effectiveness analysis in cardiac surgery: A review of its concep...
- Utility-Based Instruments for People with Dementia: A Systematic Revie...
- The health impacts of energy performance investments in low-income are...
- Approach to asymptomatic paraesophageal hernia: watchful waiting or el...
- Care Management to Reduce Disparities and Control Hypertension in Prim...
- The Chinese version of the SLEQOL is a reliable assessment of health-r...
- Team-Based Care with Pharmacists to Improve Blood Pressure: a Review o...
- Less is more: cost-effectiveness analysis of surveillance strategies f...
- Alzheimer's disease Archimedes condition‐event simulator: Development ...
- The Effect of Shorter Treatment Regimens for Hepatitis C on Population...
- Cost-effectiveness of magnetic resonance carotid plaque imaging for pr...
- Oral corticosteroid exposure and adverse effects in asthmatic patients
- Decision Analytic Markov Model Weighting Expected Benefits and Current...
- Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDge...
- Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor...
- Extending the Multiregional Input-Output Framework to Labor-Related Im...
- The cost-utility of point-of-care troponin testing to diagnose acute c...
- Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Al...
- Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With W...
- Are Evidence Standards Different for Genomic- vs. Clinical-Based Preci...
- A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease ...
- Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet ...
- Cost effectiveness of regorafenib as second-line therapy for patients ...
- Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with...
- Differential item functioning in quality of life measurement: An analy...
- Impact of health utility after thrombotic complications following tota...
- Using Patient-reported Outcome Measures to Improve Health Care
- State transition model: vorapaxar added to standard antiplatelet thera...
- Cost-effectiveness of blinatumomab versus salvage chemotherapy in rela...
- Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
- The association between observed mobility and quality of life in the n...
- Using Economic Evaluation to Illustrate Value of Care for Improving Pa...
- Implications of Coronary Artery Calcium Testing for Treatment Decision...
- Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnosti...
- Does the choice of tariff matter?
- Cost-effectiveness analysis of new generation coronary CT scanners for...
- Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium di...
- The Health Impact of Adult Cervical Deformity in Patients Presenting f...
- Health-related quality of life associated with systemic corticosteroid...
- Individualized cost-effectiveness analysis of patient-centered care: a...
- Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and ...
- Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-re...
- Prevalence of minimal hearing loss in South Korea
- Drug therapies for chronic hepatitis C infection: a cost-effectiveness...
- The epidemiology and functional outcomes of operative fixation of extr...
- CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute...
- Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS)...
- EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer...
- Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for...
- Leveraging Health-Related Quality of Life in Population Health Managem...
- Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Ris...
- Clinical outcomes and economic impact of transcatheter mitral leaflet ...
- The Cost-Effectiveness of Anterior Cruciate Ligament Reconstruction in...
- Cost Effectiveness and Cost Containment in the Era of Interferon-Free ...
- Associations with health-related quality of life after intracerebral h...
- Cost-utility analysis of physician–pharmacist collaborative interventi...
- EQ-5D Scores for Diabetes-Related Comorbidities
- Cost-effectiveness analysis of left atrial appendage occlusion compare...
- Use of low density lipoprotein particle number levels as an aid in sta...
- Factors affecting quality of life in patients on haemodialysis: a cros...
- Medical costs and quality-adjusted life years associated with smoking:...
- Study protocol for a cluster randomized controlled trial to evaluate a...
- Burden of allergic respiratory disease: a systematic review
- Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Gene...
- Costs of Health Damage from Atmospheric Emissions of Toxic Metals: Par...
- Effect of Workplace Weight Management on Health Care Expenditures and ...
- Improving the self-management of chronic pain: COping with persistent ...
- The Influence of Depression on the Life Satisfaction of the Elderly wi...
- Evaluating the Importance of Heterogeneity of Treatment Effect: Variat...
- Catalog of 199 register-based definitions of chronic conditions
- Forecasting US ivacaftor outcomes and cost in cystic fibrosis patients...
- Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendag...
- Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose W...
- Establishing Cost-Effective Allocation of Proton Therapy for Breast Ir...
- Cost–effectiveness analysis of personalized antiplatelet therapy in pa...
- Societal Implications of Health Insurance Coverage for Medically Neces...
- Multivariate Meta-Analysis of Preference-Based Quality of Life Values ...
- Economic Value of Improved Accuracy for Self-Monitoring of Blood Gluco...
- Health-related quality of life in persons with apparent treatment-resi...
- Patient burden of moderate to severe atopic dermatitis (AD): Insights ...
- Ayurvedic herbal preparations for hypercholesterolaemia
- Preference-based health-related quality of life among victims of bully...
- Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for tr...
- Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex...
- Can skin disease cause neuropathic pain? A study in pachyonychia conge...
- Quality of Life and Visual Efficiency: fifth Korea National Health and...
- Comparison of the preference-based EQ-5D-5L and SF-6D in patients with...
- Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Strat...
- Acute and chronic impact of cardiovascular events on health state util...
- CYP2C19 genotype plus platelet reactivity-guided antiplatelet therapy ...
- Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype ...
- Comparative Assessment of Different Health Utility Measures in Systemi...
- Economic evaluation of a hospital-initiated intervention for smokers w...
- Cardiovascular Disease Screening By Community Health Workers Can Be Co...
- WITHDRAWN: Cost-effectiveness analysis of left atrial appendage occlus...
- Quality of life after en bloc resection of tumors in the mobile spine
- The Health-Related Quality of Life for Patients with Myalgic Encephalo...
- Electrocardiographic Screening for Prolonged QT Interval to Reduce Sud...
- Evaluating the economic burden of psoriasis in the United States
- Prevalence and Risk Factors of Chronic Otitis Media: The Korean Nation...
- The Impact of Multimorbidity on Quality of Life Among Midlife Women: F...
- Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treat...
- Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention ...
- Prasugrel (Efient®) with percutaneous coronary intervention for treati...
- Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C ...
- Effect of Age on Cost-Effectiveness of Unicompartmental Knee Arthropla...
- Cost-effectiveness analysis of alternative screening and treatment str...
- Carotid Artery Stenosis: Cost-effectiveness of Assessment of Cerebrova...
- Utility estimates for patients with Type 2 diabetes mellitus after exp...
- Cost-Effectiveness of a Community-Based Weight Control Intervention Ta...
- Uncertainty in the Cost-Effectiveness of Federal Air Quality Regulatio...
- Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atr...
- Hospital Quality and Patient Choice: An Empirical Analysis of Mitral V...
- Universal versus genotype-guided use of direct oral anticoagulants in ...
- The Community Diabetes Education (CoDE) Program
- External costs of cadmium emissions to soil: a drawback of phosphorus ...
- US Valuation of Health Outcomes Measured Using the PROMIS-29
- A reference case for economic evaluations in osteoarthritis: An expert...
- Comparing clinician- and patient-reported outcome measures after hemic...
- Common flaws exist in published cost-effectiveness models of pharmacol...
- Clinical effectiveness and cost-effectiveness results from the randomi...
- Palmoplantar psoriasis is associated with greater impairment of health...
- Clinical- and cost-effectiveness of LDL particle-guided statin therapy...
- Dynamic Medication Adherence Modeling in Primary Prevention of Cardiov...
- Health Burden Associated with Visual Impairment in Singapore
- A Canadian cost-effectiveness analysis of transcatheter mitral valve r...
- Construct and Criterion Validity of the Euro Qol-5D in Patients with S...
- Association Between Glycated Hemoglobin and Health Utility for Type 1 ...
- Monitoring white blood cell count in adult patients with schizophrenia...
- Coût-efficacité et VHC : mise au point
- Comparison of cost-effectiveness of anticoagulation with dabigatran, r...
- Cost-Effectiveness Analysis of Extended Duration Anticoagulation with ...
- Health state utility of patients with single-level cervical degenerati...
- That’s What Friends Are For: Adolescent Peer Social Status, Health-Rel...
- Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of...
- The association between motor vehicle injuries and health-related qual...
- Health-related quality of life and socioeconomic status: inequalities ...
- Comparing Prednisone and Methotrexate to Off-label Biologic Infliximab...
- Pharmacogenetic-guided selection of warfarin versus novel oral anticoa...
- Cost effectiveness of proton therapy compared with photon therapy in t...
- Bariatric Surgery for the Treatment of Severely Obese Patients in Sout...
- RSV vaccine in development: Assessing the potential cost-effectiveness...
- A systematic literature review of cardiovascular event utilities
- An economic evaluation for prevention of diabetes mellitus in a develo...
- Cost-effectiveness of a Genetic Test for Breast Cancer Risk
- Cost-Effectiveness of Renin-Guided Treatment of Hypertension
- Comparing Five Alternative Methods of Breast Reconstruction Surgery
- Sequential Value-of-Information Assessment for Prospective Drug Safety...
- Cost-effectiveness of 64-slice CT angiography compared to conventional...
- Asthma in USA: its impact on health-related quality of life
- Comparison of the measurement properties between a short and generic i...
- Good Practice Guidelines for the use of Statistical Regression Models ...
- Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Wa...
- Cost-effectiveness of a primary care intervention to treat obesity
- A Standardized Vascular Disease Health Check in Europe: A Cost-Effecti...
- Association between Health-Related Quality of Life and Body Mass After...
- Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positiv...
- Transcatheter Aortic Valve Replacement in Nonsurgical Candidates With ...
- An assessment of the external validity of mapping QLQ-C30 to EQ-5D pre...
- Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson’s dis...
- Bowel dysfunction after total abdominal hysterectomy for benign condit...
- Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin ...
- Validity of LupusQoL-China for the Assessment of Health Related Qualit...
- Selection for early surgery in asymptomatic mitral regurgitation: A Ma...
- Disease-modifying drugs for knee osteoarthritis: can they be cost-effe...
- The impact of using different tariffs to value EQ-5D health state desc...
- Prasugrel vs clopidogrel in patients with acute coronary syndrome unde...
- Skills of the trade: valuing health risk reductions in benefit-cost an...
- Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Scr...
- Utility-based quality of life associated with overweight and obesity: ...
- Predicting SF-6D from the European Organization for Treatment and Rese...
- A systematic review and economic evaluation of new-generation computed...
- Impact of educational level on health-related quality of life (HRQL): ...
- Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etex...
- The English and Chinese versions of the five-level EuroQoL Group's fiv...
- Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed...
- Genetic testing in patients with acute coronary syndrome undergoing pe...
- The impact of Irritable Bowel Syndrome on health-related quality of li...
- Quantitative Benefit-Risk Assessment Using Only Qualitative Informatio...
- A method for the early health technology assessment of novel biomarker...
- Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal ...
- Smoke Alarm Giveaway and Installation Programs
- Using Health State Utility Values in Models Exploring the Cost-Effecti...
- Cost-Effectiveness of Computed Tomographic Angiography Before Reoperat...
- Deriving Input Parameters for Cost-Effectiveness Modeling: Taxonomy of...
- Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of ...
- Utility-Based Quality of Life Associated With Overweight and Obesity: ...
- Cost-utility of the 21-gene recurrence score assay in node-negative an...
- Impact of Comorbidity on Colorectal Cancer Screening Cost-Effectivenes...
- Markov Model for Selection of Aortic Valve Replacement Versus Transcat...
- A Risk–Benefit Assessment of Prasugrel, Clopidogrel, and Genotype-Guid...
- Using Models to Predict the Future: What to Do When the Data Run Out?
- The Impact of Co-Morbidity Burden on Preference-Based Health-Related Q...
- In Reply
- Physicians’ Actions And Influence, Such As Aggressive Blood Pressure C...
- Cost-effectiveness analysis of valsartan versus losartan and the effec...
- Cost-Effectiveness Analysis of a Community Health Worker Intervention ...
- Assessment of the Construct Validity of the EQ-5D in Patients with Acu...
- Calculating Utility Decrements Associated With an Adverse Event...
- Are Utilities Bounded at 1.0? Implications for Statistical Analysis an...
- Catalogue of EQ-5D Scores for the United Kingdom
- The Burden of Fibromyalgia: Assessment of Health Status Using the Euro...
- Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Pati...
- Estimating Health and Economic Benefits from Using Prescription Omega-...
- Quality-of-Life Implications of Immediate Surgery and Watchful Waiting...
- Estimation of the impact of diabetes-related complications on health u...
- Utility-Based Quality of Life of Overweight and Obese Adolescents
- Comparison of Rate Control versus Rhythm Control for Management of Atr...
- EuroQol (EQ-5D) health utility scores for patients with migraine
- Predicting the EuroQol Group’s EQ-5D Index from CDC’s “Healthy Days” i...
- Valuing the Health Impacts of Air Emissions
- A Quality-Adjusted Life Year of Prevention: The Cost-Effectiveness of ...
- Cost-effectiveness of continuous glucose monitoring and intensive insu...
- Modeling the lifetime costs of insulin glargine and insulin detemir in...
- Health-related quality of life, and its determinants, among older peop...
- Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Ide...
- Cost-effectiveness of statin therapy for vascular event prevention in ...
- Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bia...
- Predicting Utility for Joint Health States: A General Framework and a ...
- A comparison of physician-rated disease severity and patient reported ...
- Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D pati...
- Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Co...
- Cost-utility analysis of proton pump inhibitors and other gastro-prote...
- Analysis of Health Utility Data When Some Subjects Attain the Upper Bo...
- QALY weights for neurosensory impairments in pediatric economic evalua...
- Factors determining utility measured with the EQ-5D in patients with a...
- Risk Factors Associated With Dyspepsia in a Rural Asian Population and...
- Age at initiation and frequency of screening to detect type 2 diabetes...
- The Well-Being of Parental Caregivers of Children with Activity Limita...
- Three methods tested to model SF-6D health utilities for health states...
- The cost-effectiveness of genetic testing strategies for Lynch syndrom...
- EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematos...
- Utility Scores for Comorbid Conditions: Methodological Issues and Adva...
- A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin P...
- Health-related utility among adults with atopic dermatitis treated wit...
- CT Coronary Angiography in Patients Suspected of Having Coronary Arter...
- Reimbursement agency requirements for health related quality-of-life d...
- A Catalogue of EQ-5D Utility Weights for Chronic Diseases among Nonins...
- The cost-effectiveness of Maze procedures using ablation techniques at...
- Time Trends and Seasonal Patterns of Health-Related Quality of Life am...
- Potential Societal Savings from Reduced Sodium Consumption in the U.S....
- Predicting EQ-5D utility scores from the 25-item National Eye Institut...
- Health utility and economic analysis: theoretical and practical issues
- Hypoactive Sexual Desire Disorder in Postmenopausal Women: Quality of ...
- An updated systematic review of Health State Utility Values for osteop...
- Cost-effectiveness of warfarin: Trial versus “real-world” stroke preve...
- Estimating Preference-Based Health Utilities Index Mark 3 Utility Scor...
- Effect of Smoking Cessation Advice on Cardiovascular Disease
- Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary synd...
- Model-based simulation to explore the cost-effectiveness of following ...
- Cost-effectiveness of magnetic resonance guided focused ultrasound for...
- An economic analysis of continuous positive airway pressure for the tr...
- Relative Efficiency of the EQ-5D, HUI2, and HUI3 Index Scores in Measu...
- Personality and EQ-5D scores among individuals with chronic conditions
- Quality of life, resource consumption and costs of spinal cord stimula...
- The impact of obesity on diabetes, hyperlipidemia and hypertension in ...
- Spinal cord stimulation for failed back surgery syndrome—does it work ...
- Utilities Should Not Be Multiplied
- The Impact of Prevention on Reducing the Burden of Cardiovascular Dise...
- The Impact of Prevention on Reducing the Burden of Cardiovascular Dise...
- Economic Evaluation of the US Environmental Protection Agency's SunWis...
- Quality of Life Utilities for Pelvic Inflammatory Disease Health State...
- US Norms for Six Generic Health-Related Quality-of-Life Indexes From t...
- Health Status and Health-Related Quality of Life Preference-Based Outc...
- Current Assessment of Risk–Benefit by Regulators: Is It Time to Introd...
- The Economic Burden of Chronic Cardiovascular Disease for Major Insure...
- Mapping the EQ-5D Index from the SF-12: US General Population Preferen...
- As Good As It Gets but Good Enough for Which Applications?
- National Health Preference Data: A Useful Resource for Health Services...
- The Cost Effectiveness of Anticoagulation Management Services for Pati...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
SMDM members can access this journal content using society membership credentials.
SMDM members can access this journal content using society membership credentials.
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
